SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001681648-20-000002
Filing Date
2020-07-24
Accepted
2020-07-24 10:32:36
Documents
1
Effectiveness Date
2020-07-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8852
  Complete submission text file 0001681648-20-000002.txt   9878
Mailing Address 140 SUNHAVEN CLOSE SE CALGARY A0 T2X 2V9
Business Address 140 SUNHAVEN CLOSE SE CALGARY A0 T2X 2V9 403-909-4532
Providence Therapeutics Inc. (Filer) CIK: 0001681648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-371761 | Film No.: 201045589